Allink Biotherapeutics
PrivateLast Round
Series A
Extension
Dec 16, 2025
Total Funding Raised
$159.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Allink Biotherapeutics is a biotechnology company that develops a pipeline of First-in-Class and Best-in-Class antibody-drug conjugates and multispecific antibody therapeutics for oncology and immunology diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allink Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Allink Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 16, 2025 | ||||
| Series A | Nov 28, 2024 |
Allink Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanchi Ventures | Series A Extension, Series A |
| YuanBio Venture Capital | Series A Extension, Series A |
| Lapam Capital | Series A Extension |
| Legend Capital | Series A, Series A Extension |
| 5Y Capital | Series A Extension |
| C&D Emerging Industry Equity Investment | Series A |
| Medfine Capital | Series A, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2025
$47M raised in Series A Extension round.
- Nov 28, 2024
$42M round led by Lanchi Ventures
Allink Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allink Biotherapeutics's valuation, stock price, and market status.